HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qinghai Ye Selected Research

Biomarkers (Surrogate Marker)

10/2022Complement C5 is a novel biomarker for liver metastasis of colorectal cancer.
1/2021PNOC Expressed by B Cells in Cholangiocarcinoma Was Survival Related and LAIR2 Could Be a T Cell Exhaustion Biomarker in Tumor Microenvironment: Characterization of Immune Microenvironment Combining Single-Cell and Bulk Sequencing Technology.
3/2008EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qinghai Ye Research Topics

Disease

19Hepatocellular Carcinoma (Hepatoma)
02/2024 - 03/2008
18Neoplasms (Cancer)
02/2024 - 03/2009
12Neoplasm Metastasis (Metastasis)
12/2023 - 12/2010
5Liver Neoplasms (Liver Cancer)
01/2022 - 03/2009
4Colorectal Neoplasms (Colorectal Cancer)
12/2023 - 03/2016
3Cholangiocarcinoma
01/2022 - 01/2021
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
02/2024
1Thrombosis (Thrombus)
12/2023
1Adenocarcinoma
01/2020
1Carcinoma (Carcinomatosis)
01/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020
1Glioma (Gliomas)
01/2020
1Hypertension (High Blood Pressure)
01/2020
1Melanoma (Melanoma, Malignant)
01/2020
1Proteinuria
01/2020
1Endometrial Neoplasms (Endometrial Cancer)
01/2020
1Disease Progression
03/2016
1Hepatitis B
12/2010
1Fibrosis (Cirrhosis)
02/2004

Drug/Important Bio-Agent (IBA)

5Messenger RNA (mRNA)IBA
10/2022 - 02/2004
3Biomarkers (Surrogate Marker)IBA
10/2022 - 03/2008
3alpha-Fetoproteins (alpha-Fetoprotein)IBA
07/2018 - 03/2008
2Immune Checkpoint InhibitorsIBA
02/2024 - 01/2022
2Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2020
2Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2020 - 02/2016
2WW Domain-Containing OxidoreductaseIBA
07/2018 - 01/2018
2OsteopontinIBA
03/2016 - 04/2014
2Epithelial Cell Adhesion MoleculeIBA
03/2009 - 03/2008
1CateninsIBA
02/2024
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
12/2023
1Fatty Acids (Saturated Fatty Acids)IBA
12/2023
1Circulating Tumor DNAIBA
12/2023
1Glucose (Dextrose)FDA LinkGeneric
10/2022
1shikoninIBA
10/2022
1Complement C5 (Complement 5)IBA
10/2022
1Small Interfering RNA (siRNA)IBA
01/2022
1pembrolizumabIBA
01/2022
1Programmed Cell Death 1 ReceptorIBA
01/2022
1NivolumabIBA
01/2022
1camrelizumabIBA
01/2022
1gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
01/2021
1Sialic Acid Binding Immunoglobulin-like LectinsIBA
01/2020
1Bevacizumab (Avastin)FDA Link
01/2020
1Leucovorin (Folinic Acid)FDA Link
01/2020
1Fluorouracil (Carac)FDA LinkGeneric
01/2020
1ChemokinesIBA
01/2020
1Glycogen Synthase KinasesIBA
01/2019
1Tyrosine (L-Tyrosine)FDA Link
01/2019
1AntibodiesIBA
01/2019
1Antineoplastic Agents (Antineoplastics)IBA
01/2019
1Interleukin-6 (Interleukin 6)IBA
01/2019
1ARQ 197IBA
01/2019
1capmatinibIBA
01/2019
1Disulfiram (Antabuse)FDA Link
01/2019
1CopperIBA
01/2019
1LigandsIBA
01/2019
1TOR Serine-Threonine KinasesIBA
12/2017
1Adenosine Monophosphate (AMP)IBA
01/2017
1Carrier Proteins (Binding Protein)IBA
01/2017
1EnzymesIBA
01/2017
1SirtuinsIBA
01/2017
1VimentinIBA
03/2016
1Cetuximab (Erbitux)FDA Link
03/2016
1PlatinumIBA
02/2016
1elemeneIBA
02/2016
1DNA AdductsIBA
02/2016
1Copper Transporter 1IBA
02/2016
1Plant ExtractsIBA
02/2016
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2013
1CytokinesIBA
12/2010
1Interleukin-2 (IL2)IBA
12/2010
1Interleukin-15 (Interleukin 15)IBA
12/2010
1beta CateninIBA
03/2009
1Complementary DNA (cDNA)IBA
02/2004

Therapy/Procedure

7Therapeutics
02/2024 - 03/2016
5Immunotherapy
02/2024 - 12/2017
3Hepatectomy
12/2023 - 04/2016
2Drug Therapy (Chemotherapy)
01/2023 - 03/2016
2Neoadjuvant Therapy
01/2022 - 01/2014
1Transplantation
02/2016
1Chemoprevention
02/2004